drugset / Trial / NCT05601648
PET Synaptogenesis After Psilocybin In DEpression Recovery
NaSingle-groupOpen-labelTreatment
Summary
Participants with depression will be given a single dose of psilocybin and supportive psychotherapy before, during, and after drug administration. Participants will undergo positron emission tomography (PET) imaging before and one week after psilocybin using a marker of synaptic density. This design allows us to assess the relationship between neurotrophic, and antidepressant effects produced by psilocybin.
Timeline
- Start
- 2023-07-01
- Primary completion
- 2025-01-01
- Completion
- 2025-07-01
Outcome
Outcome not reported
Stopped: “Due to negative results in similar trials using 11C-UCB-J”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | — |